
Ai-biopharma is a biopharma company specializing in medicinal chemistry research and the discovery and development of drugs for human diseases. They offer in-silico solutions including Chemoinformatics, Molecular Modeling, Docking, Data analysis, and SAR formatting/interpretation, powered by an Artificial Intelligence platform to accelerate drug design for preclinical candidates. With expertise in Antiviral, Nucleoside, Nucleotides, Prodrug targeting, and small molecule medicinal chemistry, they also provide consulting services and are developing their own drug candidates for viral diseases like Hepatitis B. The company operates from its dedicated chemistry laboratories and offices in Montpellier, France.

Ai-biopharma is a biopharma company specializing in medicinal chemistry research and the discovery and development of drugs for human diseases. They offer in-silico solutions including Chemoinformatics, Molecular Modeling, Docking, Data analysis, and SAR formatting/interpretation, powered by an Artificial Intelligence platform to accelerate drug design for preclinical candidates. With expertise in Antiviral, Nucleoside, Nucleotides, Prodrug targeting, and small molecule medicinal chemistry, they also provide consulting services and are developing their own drug candidates for viral diseases like Hepatitis B. The company operates from its dedicated chemistry laboratories and offices in Montpellier, France.